Kyleena (Levonorgestrel)

Levonorgestrel released from Kyleena acts locally on the uterine lining and cervical mucus. It suppresses endometrial growth, thickens cervical mucus to block sperm entry, and reduces tubal motility, creating conditions that prevent fertilisation and implantation.

The dosing regimen for Kyleena is determined by a qualified prescriber. The device contains a fixed amount of 19.5 mg levonorgestrel and is inserted once, providing continuous contraceptive effect for up to five years without the need for daily dosing.

Kyleena is contraindicated in pregnancy (Category X) and should not be used by women who are or may become pregnant. For breastfeeding women, the device may be used after discussion with a healthcare professional, as levonorgestrel is excreted in low amounts in breast milk.

To order Kyleena, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with copper IUDs, Kyleena releases a progestin rather than copper, resulting in fewer menstrual changes and a lower incidence of heavy bleeding. Its 19.5 mg levonorgestrel load offers up to five years of protection, whereas some alternatives may have different hormone doses or durations.

Kyleena should be stored at room temperature, below 25 °C, in its original sealed packaging. Protect the device from moisture, direct sunlight and extreme temperatures to maintain its integrity until the time of insertion.

Kyleena is administered by a trained healthcare professional who inserts the intrauterine system through the cervix into the uterine cavity. The procedure is performed in a clinical setting under sterile conditions, and the device remains in place for up to five years unless removal is required.

Serious risks include uterine perforation during insertion, expulsion of the device, pelvic inflammatory disease, and the rare possibility of ectopic pregnancy if conception occurs. Patients should seek immediate medical attention if they experience severe abdominal pain, abnormal bleeding or signs of infection.

Kyleena is contraindicated for women who are pregnant, have active pelvic infections, known or suspected uterine anomalies, unexplained vaginal bleeding, or a history of breast cancer. It should also be avoided by individuals with hypersensitivity to levonorgestrel or any component of the device.